Old Web
PHASE III SAFETY EVALUATION OF CYCLOSPORINE 0.1% OPHTHALMIC EMULSION ADMINISTERED TWICE DAILY TO DRY EYE DISEASE PATIENTS FOR UP TO 3 YEARS
2006
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI